Michael Huber

6.6k total citations
156 papers, 5.1k citations indexed

About

Michael Huber is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Michael Huber has authored 156 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 43 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Michael Huber's work include Mast cells and histamine (51 papers), PI3K/AKT/mTOR signaling in cancer (18 papers) and Veterinary Equine Medical Research (13 papers). Michael Huber is often cited by papers focused on Mast cells and histamine (51 papers), PI3K/AKT/mTOR signaling in cancer (18 papers) and Veterinary Equine Medical Research (13 papers). Michael Huber collaborates with scholars based in Germany, United States and Canada. Michael Huber's co-authors include Gerald Krystal, Jacqueline E. Damen, Janet Kalesnikoff, Dietrich Keppler, Michael R. Hughes, Martin Rössle, V. Siegerstetter, Cheryl D. Helgason, R. Keith Humphries and Michael Reth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michael Huber

153 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Huber Germany 38 2.1k 1.5k 871 799 577 156 5.1k
M Salmon United Kingdom 42 2.0k 0.9× 1.4k 0.9× 1.1k 1.2× 394 0.5× 564 1.0× 127 5.6k
David Dombrowicz France 43 2.6k 1.2× 1.4k 0.9× 1.9k 2.2× 709 0.9× 661 1.1× 109 5.9k
Gregory L. Stahl United States 56 4.8k 2.3× 1.9k 1.3× 1.1k 1.2× 1.5k 1.8× 896 1.6× 169 10.2k
Shuang Yu China 38 2.4k 1.1× 2.1k 1.4× 769 0.9× 474 0.6× 609 1.1× 135 6.4k
Juan Zhang China 39 2.5k 1.2× 3.2k 2.1× 675 0.8× 552 0.7× 610 1.1× 211 6.5k
Yasuyuki Sasaguri Japan 53 1.4k 0.6× 2.9k 2.0× 977 1.1× 1.3k 1.6× 850 1.5× 238 8.0k
Athena Chalaris Germany 32 2.1k 1.0× 1.9k 1.2× 633 0.7× 484 0.6× 692 1.2× 46 6.3k
Manfred Herold Austria 43 1.9k 0.9× 1.1k 0.7× 582 0.7× 658 0.8× 1.1k 1.8× 201 6.4k
Gerald M. Fuller United States 41 1.7k 0.8× 1.8k 1.2× 720 0.8× 578 0.7× 906 1.6× 98 6.5k
Vivian Barak Israel 41 1.4k 0.6× 1.2k 0.8× 398 0.5× 555 0.7× 619 1.1× 178 5.9k

Countries citing papers authored by Michael Huber

Since Specialization
Citations

This map shows the geographic impact of Michael Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Huber more than expected).

Fields of papers citing papers by Michael Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Huber. The network helps show where Michael Huber may publish in the future.

Co-authorship network of co-authors of Michael Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Huber. A scholar is included among the top collaborators of Michael Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Huber. Michael Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huber, Michael, et al.. (2025). Anle138b mitigates post-hypoxic cognitive impairment, α-Synuclein aggregation and UPR activation in Drosophila melanogaster. Acta Neuropathologica Communications. 13(1). 230–230.
2.
Ahmed, Nabil, Christian Preisinger, Thomas Wilhelm, & Michael Huber. (2024). TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell Leukemia Cell Line HMC-1.2. Cells. 13(9). 747–747. 2 indexed citations
3.
Schemionek, Mirle, Michael Huber, Margherita Vieri, et al.. (2023). XBP1 promotes NRASG12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS. Journal of Cellular and Molecular Medicine. 27(21). 3363–3377. 1 indexed citations
4.
Vieri, Margherita, Ivan G. Costa, Tiago Maié, et al.. (2023). Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients. Frontiers in Pharmacology. 14. 1212392–1212392. 2 indexed citations
5.
Voigt, Aaron, et al.. (2021). Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin. International Journal of Molecular Sciences. 22(21). 11586–11586. 14 indexed citations
6.
Goldmann, Tobias, Marco Prinz, Michael Huber, et al.. (2021). Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner. Translational Stroke Research. 13(3). 462–482. 33 indexed citations
7.
Obiedat, Akram, Amit Rimon, Gordon McLennan, et al.. (2020). Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nature Communications. 11(1). 1304–1304. 45 indexed citations
8.
Huber, Michael, Andrew C.B. Cato, George K. Ainooson, et al.. (2019). Regulation of the pleiotropic effects of tissue-resident mast cells. Journal of Allergy and Clinical Immunology. 144(4). S31–S45. 43 indexed citations
9.
Habib, Pardes, Jörg B. Schulz, Arno Reich, et al.. (2019). EPO and TMBIM3/GRINA Promote the Activation of the Adaptive Arm and Counteract the Terminal Arm of the Unfolded Protein Response after Murine Transient Cerebral Ischemia. International Journal of Molecular Sciences. 20(21). 5421–5421. 16 indexed citations
10.
Weiskirchen, Ralf, Steffen K. Meurer, Christian Liedtke, & Michael Huber. (2019). Mast Cells in Liver Fibrogenesis. Cells. 8(11). 1429–1429. 39 indexed citations
11.
12.
Sadick, Haneen, et al.. (2014). Endoscopic Forehead Approach for Minimally Invasive Benign Tumor Excisions. JAMA Facial Plastic Surgery. 16(5). 352–358. 14 indexed citations
13.
Fejér, György, Ildikó Győry, Idan Cohen, et al.. (2013). Nontransformed, GM-CSF–dependent macrophage lines are a unique model to study tissue macrophage functions. Proceedings of the National Academy of Sciences. 110(24). E2191–8. 82 indexed citations
14.
Huber, Michael. (2010). Combinatorial Designs for Authentication and Secrecy Codes. 5(6). 581–675. 2 indexed citations
15.
Hermiston, Michelle L., et al.. (2009). Requirement for CD45 in fine-tuning mast cell responses mediated by different ligand–receptor systems. Cellular Signalling. 21(8). 1277–1286. 22 indexed citations
16.
Gibbs, Bernhard F., et al.. (2007). Substantial differences in the kinetics of histamine release from human basophils caused by varying strengths of IgE-dependent activators.. Inflammation Research. 56. 1 indexed citations
17.
Clayton, Leigh A., et al.. (1999). What is Your Diagnosis?. Journal of the American Veterinary Medical Association. 214(6). 781–784. 1 indexed citations
18.
Riebold, Thomas W., et al.. (1994). Orotracheal and nasotracheal intubation in llamas. Journal of the American Veterinary Medical Association. 204(5). 779–783. 9 indexed citations
19.
Grubb, Tamara, Thomas W. Riebold, & Michael Huber. (1992). Comparison of lidocaine, xylazine, and xylazine/lidocaine for caudal epidural analgesia in horses. Journal of the American Veterinary Medical Association. 201(8). 1187–1190. 71 indexed citations
20.
Huber, Michael, et al.. (1992). Fate and effect of autogenous osteochondral fragments implanted in the middle carpal joint of horses. American Journal of Veterinary Research. 53(9). 1579–1588. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Salmon Breakdown of academic impact, for papers by David Dombrowicz Breakdown of academic impact, for papers by Gregory L. Stahl Breakdown of academic impact, for papers by Shuang Yu Breakdown of academic impact, for papers by Juan Zhang Breakdown of academic impact, for papers by Yasuyuki Sasaguri Breakdown of academic impact, for papers by Athena Chalaris Breakdown of academic impact, for papers by Manfred Herold Breakdown of academic impact, for papers by Gerald M. Fuller Breakdown of academic impact, for papers by Vivian Barak
Rankless by CCL
2026